RHOA and mesothelioma: Collectively, these findings indicate that activation of RhoA/ROCK signaling contributes to YAP hyperactivity in pleural mesothelioma and inhibitors of RhoA/ROCK could be used to suppress YAP activity and thereby decrease cell viability of mesothelioma cells.